Levosalbutamol 0.63 mg + Ipratropium Bromide 500.00 MCG

IPRAZEST PD is a combination medication designed for the management of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). It contains Levosalbutamol, a selective beta2-adrenergic receptor agonist that relaxes the smooth muscles in the airways, and Ipratropium Bromide, an anticholinergic agent that helps to open up the airways. IPRAZEST PD provides quick relief from bronchospasm, improves breathing, and helps to enhance lung function. It is presented in respules form for inhalation, ensuring effective delivery of medication to the target site. This combination medication offers a comprehensive approach to respiratory symptom relief and helps improve overall respiratory health.

IPRAZEST PD is for inhalation use only. Open the respule and empty the entire contents into a nebulizer. Breathe in the medication through a mouthpiece or face mask as directed by your doctor. It is important to follow the recommended dosage and frequency of use given by your healthcare professional.

Allopathic

The contents and information provided here are solely intended to provide a general overview of the products and medicines and must be used for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. The information contained herein should not be used as a substitute for the advice of a qualified physician. For all queries or doubts related to your medical condition, we highly recommend that you consult your registered medical practitioner.